JY
HIMS icon

Jeff Yass’s Hims & Hers Health HIMS Stock Holding History

Jeff Yass’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$469M Buy
13,539,700
+688,800
+5% +$18.5M 0.04% 324
2026
Q1 		$267M Buy
12,850,900
+5,110,200
+66% +$121M 0.03% 421
2025
Q4 		$251M Sell
7,740,700
-691,800
-8% -$29.6M 0.03% 453
2025
Q3 		$478M Buy
8,432,500
+149,700
+2% +$7.67M 0.05% 273
2025
Q2 		$413M Buy
8,282,800
+3,694,700
+81% +$167M 0.06% 254
2025
Q1 		$136M Buy
4,588,100
+1,207,800
+36% +$44.9M 0.02% 528
2024
Q4 		$81.7M Buy
3,380,300
+1,794,200
+113% +$44.4M 0.01% 828
2024
Q3 		$29.2M Sell
1,586,100
-380,000
-19% -$6.8M 0.01% 1482
2024
Q2 		$39.7M Buy
1,966,100
+738,300
+60% +$12.3M 0.01% 1139
2024
Q1 		$19M Buy
1,227,800
+599,100
+95% +$6.75M ﹤0.01% 1840
2023
Q4 		$5.6M Sell
628,700
-111,600
-15% -$825K ﹤0.01% 3521
2023
Q3 		$4.66M Buy
740,300
+125,400
+20% +$933K ﹤0.01% 3659
2023
Q2 		$5.78M Sell
614,900
-220,300
-26% -$2.18M ﹤0.01% 3301
2023
Q1 		$8.29M Buy
835,200
+301,700
+57% +$2.64M ﹤0.01% 2724
2022
Q4 		$3.42M Sell
533,500
-28,700
-5% -$163K ﹤0.01% 3812
2022
Q3 		$3.14M Buy
562,200
+131,600
+31% +$793K ﹤0.01% 3995
2022
Q2 		$1.95M Buy
430,600
+181,500
+73% +$774K ﹤0.01% 4968
2022
Q1 		$1.33M Buy
249,100
+67,400
+37% +$333K ﹤0.01% 6431
2021
Q4 		$1.19M Sell
181,700
-431,500
-70% -$3.12M ﹤0.01% 6830
2021
Q3 		$4.62M Buy
613,200
+125,600
+26% +$1.06M ﹤0.01% 4100
2021
Q2 		$5.31M Sell
487,600
-112,500
-19% -$1.34M ﹤0.01% 3933
2021
Q1 		$7.94M Buy
+600,100
New +$10.1M ﹤0.01% 3150

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jeff Yass's HIMS Position: Q2 2026 in Review

Jeff Yass reduced its Hims & Hers Health (HIMS) stake by 98% in Q2 2026, selling an estimated $43.1M and leaving 28,950 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #8187.

Jeff Yass first reported a position in HIMS in Q1 2021 and has held it in 21 quarters since. The position peaked at $67.8M in Q3 2025. 504 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Jeff Yass held 28,950 shares of Hims & Hers Health worth $1M as of Q2 2026.
  • Jeff Yass sold 1,605,791 Hims & Hers Health shares in Q2 2026, an estimated $43.1M.
  • Hims & Hers Health made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #8187 holding.
  • Jeff Yass first reported a position in Hims & Hers Health in Q1 2021 and has held it in 21 quarters since.
  • Jeff Yass's Hims & Hers Health position peaked at $67.8M in Q3 2025.
  • 504 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.